Verrica Pharmaceuticals is dedicated to developing and commercializing treatments for dermatological conditions, including skin cancers. Their primary product, YCANTH® (cantharidin), is the first and only FDA-approved treatment administered by healthcare professionals for molluscum contagiosum in patients aged two and older. Verrica is also investigating VP-315, an injectable oncolytic peptide, for basal cell carcinoma and has initiated a global Phase 3 program for VP-102 (YCANTH®) for Common Warts. Verrica offers a fast-paced, small-pharma environment where unique skills are valued.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level